Revenue
2022
2023
2024
2025
Immunic, Inc. (IMUX)
Price$13.11Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — |
| Research & development | $82.0M | $80.0M | $83.2M | $71.3M | $61.1M | $38.6M | $22.5M | $9.6M | $39.3M | $30.0M | $39.8M | $39.5M | $21.8M | $5.1M |
| Operating expenses | $103.2M | $98.1M | $99.2M | $119.5M | $91.7M | $49.0M | $37.0M | $12.0M | $52.7M | $41.3M | $52.1M | $50.3M | $31.4M | $9.6M |
| Operating income | −$103.2M | −$98.1M | −$99.2M | −$119.5M | −$91.7M | −$49.0M | −$37.0M | −$12.0M | −$52.7M | −$41.3M | −$52.1M | −$50.3M | −$31.4M | −$9.6M |
| EBITDA | −$103.1M | −$97.9M | −$99.1M | −$119.4M | −$91.6M | −$48.9M | −$37.0M | −$12.0M | −$51.7M | −$39.5M | −$50.8M | −$49.3M | −$30.6M | −$8.9M |
| Net income | −$97.2M | −$100.5M | −$93.6M | −$120.4M | −$92.9M | −$44.0M | −$34.9M | −$11.5M | −$52.1M | −$41.0M | −$52.0M | −$47.7M | −$32.7M | −$6.7M |
| Basic EPSper basic share | -$0.62 | -$1.00 | -$2.11 | -$3.78 | -$3.93 | -$2.81 | -$4.52 | -$13.63 | -$2,620.00 | -$2,620.00 | -$4,140.00 | -$7,080.00 | -$149,720.00 | -$35,780.00 |
| Diluted EPSper diluted share | -$0.62 | -$1.00 | -$2.11 | -$3.78 | -$3.93 | -$2.81 | -$4.52 | -$13.63 | -$2,620.00 | -$2,620.00 | -$4,140.00 | -$7,080.00 | -$149,720.00 | -$35,780.00 |
Owners
Reported shareholders
6.04%of listed shares
Aberdeen Group plc824.39K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Aberdeen Group plc | 6.04%824.39K shares |
BVF INC/IL | 5.61%765.3K shares |
MILLENNIUM MANAGEMENT LLC | 5.43%740.35K shares |
Avidity Partners Management LP | 4.91%669.94K shares |
BRAIDWELL LP | 4.73%645.01K shares |
Laurion Capital Management LP | 4.47%610.33K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.19%571.56K shares |
Jones Hill Capital LP | 3.96%539.81K shares |
Nantahala Capital Management, LLC | 3.67%501.29K shares |
Woodline Partners LP | 3.46%471.53K shares |
Soleus Capital Management, L.P. | 3.30%450K shares |
Vitt Daniel | ≈2.87%391.88K shares |
Propel Bio Management, LLC | 2.38%325.02K shares |
Rudick Richard Alan | ≈1.69%230.38K shares |
Neermann Joerg | ≈1.47%200K shares |
UBS Group AG | 1.29%175.76K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.25%170.68K shares |
683 Capital Management, LLC | 1.08%147.25K shares |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.03%139.86K shares |
BlackRock, Inc. | 0.97%132.79K shares |
Percentages use 13.64M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 13, 2025Form 4 | Nash DuaneExecutive Chairman | BuyCommon Stock | 20.0K | $0.83 | $16.6K | 36.0K |
| Jun 5, 2025Form 4/A | Tardio JasonPresident and COO | BuyCommon Stock | 12.5K | $0.79 | $9.9K | 12.5K |
| Jun 5, 2025Form 4 | Tardio JasonPresident and COO | BuyCommon Stock | 12.5K | $0.79 | $9.9K | 12.5K |
| Jun 5, 2025Form 4 | Neermann JoergDirector | BuyCommon Stock | 30.0K | $0.76 | $22.8K | 200.0K |
| Jun 4, 2025Form 4/A | Vitt DanielCEO and Director | BuyCommon Stock | 15.0K | $0.77 | $11.6K | 29.0K |